Myocardial Infarction in Kawasaki Disease

Sunil J Ghelani1, Annette L Baker1, Kevin Friedman1

  • 1Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA.

PubMed
Abstract

Insights

Myocardial infarction (MI) in Kawasaki disease (KD) patients often goes undiagnosed, leading to adverse outcomes. Early detection and management are crucial, especially for those with giant coronary artery aneurysms.

Area of Science:

  • Cardiology
  • Pediatric Rheumatology
  • Vascular Medicine

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Coronary artery aneurysms are a known complication of KD, increasing the risk of myocardial infarction (MI).
  • Understanding the clinical trajectory of MI in KD patients is essential for improving outcomes.

Purpose of the Study:

  • To investigate the clinical features, diagnostic approaches, treatment strategies, and patient outcomes for myocardial infarction (MI) in individuals with a history of Kawasaki disease (KD).

Main Methods:

  • A retrospective analysis of patients diagnosed with both KD and MI between 1984 and 2023 at a single center.
  • Data included patient demographics, KD onset, MI diagnosis methods, timing of MI relative to KD, coronary artery status, interventions, and clinical outcomes.
  • Review of medical records, imaging findings (including MRI), and procedural data.

Main Results:

  • Twenty-two patients with KD experienced MI, predominantly males (86%), with a median KD onset at 14 months.
  • MI was diagnosed during acute illness (32%), via surveillance (36%), or other tests (18%).
  • Most MIs occurred within 2 years of KD diagnosis (81%), in patients with large/giant coronary artery aneurysms, primarily in the left anterior descending artery. Interventions included bypass surgery (7 patients) and PCI (1 patient).

Conclusions:

  • A significant proportion of MI cases in KD patients were missed, underscoring the need for enhanced early detection and management protocols.
  • While giant aneurysms were present in all MI cases, other contributing risk factors require further investigation.
  • Future research should focus on computational modeling and genetic factors to personalize antithrombotic therapy and optimize care for high-risk KD patients.